These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17195079)

  • 1. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
    Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
    Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
    Ou X; Cai S; Liu P; Zeng J; He Y; Wu X; Du J
    J Cancer Res Clin Oncol; 2008 May; 134(5):525-33. PubMed ID: 17909857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model.
    Zheng X; Koropatnick J; Chen D; Velenosi T; Ling H; Zhang X; Jiang N; Navarro B; Ichim TE; Urquhart B; Min W
    Int J Cancer; 2013 Feb; 132(4):967-77. PubMed ID: 22870862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.
    Braun D; Longman RS; Albert ML
    Blood; 2005 Oct; 106(7):2375-81. PubMed ID: 15947091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition.
    Zhu L; Ji F; Wang Y; Zhang Y; Liu Q; Zhang JZ; Matsushima K; Cao Q; Zhang Y
    J Immunol; 2006 Dec; 177(11):8226-33. PubMed ID: 17114500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.
    von Bergwelt-Baildon MS; Popov A; Saric T; Chemnitz J; Classen S; Stoffel MS; Fiore F; Roth U; Beyer M; Debey S; Wickenhauser C; Hanisch FG; Schultze JL
    Blood; 2006 Jul; 108(1):228-37. PubMed ID: 16522817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
    Hwang SL; Chung NP; Chan JK; Lin CL
    Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
    Holtzhausen A; Zhao F; Evans KS; Tsutsui M; Orabona C; Tyler DS; Hanks BA
    Cancer Immunol Res; 2015 Sep; 3(9):1082-95. PubMed ID: 26041736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
    Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
    Front Immunol; 2020; 11():120. PubMed ID: 32117271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.
    Li W; Katz BP; Spinola SM
    Infect Immun; 2011 Aug; 79(8):3338-47. PubMed ID: 21576329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
    Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
    Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model.
    Liu K; Yang Y; Chen Y; Li S; Gong Y; Liang Y
    Int Urol Nephrol; 2020 Feb; 52(2):399-407. PubMed ID: 31894556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.
    Eleftheriadis T; Pissas G; Sounidaki M; Tsogka K; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
    Int J Mol Med; 2016 Nov; 38(5):1605-1613. PubMed ID: 27667153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma.
    Maneechotesuwan K; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Yaikwawong M; Barnes PJ; Wongkajornsilp A
    J Allergy Clin Immunol; 2009 Jan; 123(1):239-48. PubMed ID: 19058839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
    Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
    Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses.
    Sioud M; Mobergslien A; Sæbøe-Larssen S
    Methods Mol Biol; 2015; 1218():269-76. PubMed ID: 25319657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.